[1]
Pothiaraj, G., Saxena, S., Manoranjani, M., Pitchaikani, S., Saravanan, K. and Shakila, H. 2024. Development of a recombinant construct as an immunogenic target for leptospirosis using LipL41 and molecular adjuvants. Biomedical Research and Therapy. 11, 9 (Sep. 2024), 6775-6785. DOI:https://doi.org/10.15419/bmrat.v11i9.921.